The emerging therapy of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide472136.blogsumer.com/40863423/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment